![Stephen Sherwin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Sherwin
Director/Board Member at
NEUROCRINE BIOSCIENCES, INC.
Net worth: 5 M $ as of 31/05/2026
Profile
Stephen A. Sherwin was the founder of Ceregene, Inc., founded in 2001, where the title held was Chairman from 2001 to 2013.
Dr. Sherwin was the founder of Abgenix, Inc., founded in 1996, where the title held was Chairman from 1996 to 2006.
Current jobs include Independent Director at Neurocrine Biosciences, Inc. since 1999; Independent Director at Biogen, Inc. since 2010; Director at Avertix Medical, Inc.; Director at Rheos Medicines, Inc.; Independent Non-Executive Director at Innovent Biologics, Inc. starting 2025; Member at American Society of Clinical Oncology, Inc.; Member at American Association for Cancer Research; Advisory partner at Third Rock Ventures LLC since 2016; Member-Supervisory Board at Biogen GmbH since 2010; Clinical Professor at the University of California; Clinical Professor-Medicine at The University of California, San Francisco since 2010.
Former jobs include Chairman & Chief Executive Officer at Cell Genesys, Inc. from 1994 to 2009; Chairman at Biotechnology Innovation Organization from 2009 to 2011; Independent Director at Vical, Inc. from 2014 to 2015; Director at ANI Pharmaceuticals, Inc. from 2009 to 2013; Independent Director at Rigel Pharmaceuticals, Inc. from 2000 to 2017; Independent Director at Aduro BioTech, Inc. from 2015 to 2020; Director at Biogen Idec New Ventures, Inc.; Independent Director at Verastem, Inc. from 2013 to 2016; Independent Director at BioNTech US, Inc. from 2015 to 2020; Independent Director at BioPlus Acquisition Corp.
from 2021 to 2023; Independent Director at Epiphany Technology Acquisition Corp.
from 2022 to 2023; Vice President-Clinical Research at Genentech, Inc. from 1983 to 1990; Member at President's Council of Advisors on Science & Technology from 2011 to 2013.
Education includes undergraduate degree from Yale University conferred in 1970 and doctorate from Harvard Medical School conferred in 1974.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOGEN INC. 0.01% | 09/06/2026 | 15,193 ( 0.01% ) | 3 M $ | 31/05/2026 |
| 05/06/2026 | 15,860 ( 0.02% ) | 3 M $ | 31/05/2026 | |
| 30/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Stephen Sherwin active positions
| Companies | Position | Start |
|---|---|---|
| BIOGEN INC. | Director/Board Member | 01/01/2010 |
| NEUROCRINE BIOSCIENCES, INC. | Director/Board Member | 01/04/1999 |
| INNOVENT BIOLOGICS, INC. | Director/Board Member | 26/08/2025 |
Avertix Medical Systems, Inc.
 Avertix Medical Systems, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiac medical devices | Director/Board Member | - |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm targets companies operating in the fields of the healthcare sector. It provides financing for early stage capital requirements. It acts as a lead investor. | Consultant / Advisor | 01/01/2016 |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Biogen GmbH
 Biogen GmbH Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and supplies pharmaceutical products | Director/Board Member | 01/01/2010 |
Rheos Medicines, Inc.
 Rheos Medicines, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease | Director/Board Member | - |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Corporate Officer/Principal | - |
| ░░░ ░░░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Former positions of Stephen Sherwin
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Stephen Sherwin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
79
1st degree connections
28
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 28 |
|---|---|
Cell Genesys, Inc.
 Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Vical, Inc.
 Vical, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Abgenix, Inc.
 Abgenix, Inc. BiotechnologyHealth Technology Develops therapeutic products | Health Technology |
ANI Pharmaceuticals, Inc.
 ANI Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in the developing, manufacturing and marketing of generic pharmaceutical products | Health Technology |
Rigel Pharmaceuticals, Inc.
 Rigel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which discovers, develops and provides novel small-molecule drugs | Health Technology |
Ceregene, Inc.
 Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for neurodegenerative disorders | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Aduro BioTech, Inc.
 Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company, which focuses on the development of technology platforms for cancer | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
President's Council of Advisors on Science & Technology
 President's Council of Advisors on Science & Technology General GovernmentGovernment Provides the Administration services to science and technology | Government |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm targets companies operating in the fields of the healthcare sector. It provides financing for early stage capital requirements. It acts as a lead investor. | Finance |
Avertix Medical Systems, Inc.
Avertix Medical Systems, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiac medical devices | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and supplies pharmaceutical products | Health Technology |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innovent Biologics, Inc.
 Innovent Biologics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
BioNTech US, Inc.
 BioNTech US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for cancer | Health Technology |
Rheos Medicines, Inc.
Rheos Medicines, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease | Health Technology |
Epiphany Technology Acquisition Corp.
 Epiphany Technology Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
BioPlus Acquisition Corp.
 BioPlus Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
- Stock Market
- Insiders
- Stephen Sherwin
